Sharon Tan

Investor

Executive in Residence at Iaso Ventures

About

Executive in Residence with over 20 years in clinical and preclinical development and pipeline strategy, focused on rare diseases and gene therapy, with prior program leadership at Garuda Therapeutics, enGene, Ultragenyx and Sanofi Genzyme.

LinkedIn ↗

Colleagues at Iaso Ventures

Anil S. Jina

Executive in Residence at Iaso Ventures

Chandra Ramanathan

Advisor, Biotech at Iaso Ventures

John Reynders

Chief Data Scientist & Venture Partner at Iaso Ventures

Mark G. Currie

Venture Partner at Iaso Ventures

Maurizio Fava

Advisor, Clinical R&D at Iaso Ventures

Michael Fenn

Venture Partner at Iaso Ventures

Noah J. Richmond

Advisor, Legal & IP at Iaso Ventures

Raymond Sanchez

Advisor, Drug Development at Iaso Ventures